SDC1 and central nervous system cancer: Our study proposed, for the first time, that SPP1/HMOX1 contributeso the activation of the PI3K/AKT, JAK–STAT and syndecan 1 signalling pathways, thereby maintaining the motility and malignancy of glioma cells.